| Palmitic and oleic acid: the yin and yang of fatty acids in type 2 diabetes mellitus X Palomer, J Pizarro-Delgado, E Barroso, M Vázquez-Carrera Trends in Endocrinology & Metabolism 29 (3), 178-190, 2018 | 555 | 2018 |
| An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy X Palomer, L Salvadó, E Barroso, M Vázquez-Carrera International journal of cardiology 168 (4), 3160-3172, 2013 | 330 | 2013 |
| Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model A Cano, M Ettcheto, JH Chang, E Barroso, M Espina, BA Kühne, ... Journal of Controlled Release 301, 62-75, 2019 | 270 | 2019 |
| Targeting endoplasmic reticulum stress in insulin resistance L Salvado, X Palomer, E Barroso, M Vázquez-Carrera Trends in Endocrinology & Metabolism 26 (8), 438-448, 2015 | 243 | 2015 |
| Oleate prevents saturated-fatty-acid-induced ER stress, inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism L Salvadó, T Coll, AM Gómez-Foix, E Salmeron, E Barroso, X Palomer, ... Diabetologia 56, 1372-1382, 2013 | 234 | 2013 |
| Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease I Pedrós, D Petrov, M Allgaier, F Sureda, E Barroso, C Beas-Zarate, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (9 …, 2014 | 215 | 2014 |
| The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty … E Barroso, R Rodríguez-Calvo, L Serrano-Marco, AM Astudillo, J Balsinde, ... Endocrinology 152 (5), 1848-1859, 2011 | 202 | 2011 |
| High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents D Petrov, I Pedrós, G Artiach, FX Sureda, E Barroso, M Pallàs, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …, 2015 | 184 | 2015 |
| SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation X Palomer, MS Román-Azcona, J Pizarro-Delgado, A Planavila, ... Signal transduction and targeted therapy 5 (1), 14, 2020 | 130 | 2020 |
| PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism L Salvadó, E Barroso, AM Gómez-Foix, X Palomer, L Michalik, W Wahli, ... Diabetologia 57, 2126-2135, 2014 | 117 | 2014 |
| Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease M Zarei, E Barroso, X Palomer, J Dai, P Rada, T Quesada-López, ... Molecular metabolism 8, 117-131, 2018 | 109 | 2018 |
| Peroxisome proliferator-activated receptor (PPAR) β/δ: a new potential therapeutic target for the treatment of metabolic syndrome T Coll, R Rodríguez-Calvo, E Barroso, L Serrano, E Eyre, X Palomer, ... Current molecular pharmacology 2 (1), 46-55, 2009 | 107 | 2009 |
| Activation of peroxisome proliferator-activated receptor-δ by GW501516 prevents fatty acid-induced nuclear factor-κB activation and insulin resistance in skeletal muscle cells T Coll, D Alvarez-Guardia, E Barroso, AM Gomez-Foix, X Palomer, ... Endocrinology 151 (4), 1560-1569, 2010 | 104 | 2010 |
| PPARβ/δ: a key therapeutic target in metabolic disorders X Palomer, E Barroso, J Pizarro-Delgado, L Peña, G Botteri, M Zarei, ... International journal of molecular sciences 19 (3), 913, 2018 | 102 | 2018 |
| Targeting FGF21 for the treatment of nonalcoholic steatohepatitis M Zarei, J Pizarro-Delgado, E Barroso, X Palomer, M Vázquez-Carrera Trends in pharmacological sciences 41 (3), 199-208, 2020 | 90 | 2020 |
| The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through … E Barroso, E Eyre, X Palomer, M Vázquez-Carrera Biochemical pharmacology 81 (4), 534-543, 2011 | 90 | 2011 |
| The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and … L Serrano-Marco, E Barroso, I El Kochairi, X Palomer, L Michalik, W Wahli, ... Diabetologia 55, 743-751, 2012 | 88 | 2012 |
| PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells X Palomer, E Capdevila-Busquets, G Botteri, L Salvadó, E Barroso, ... International journal of cardiology 174 (1), 110-118, 2014 | 81 | 2014 |
| Atorvastatin prevents carbohydrate response element binding protein activation in the fructose‐fed rat by activating protein kinase A R Rodríguez‐Calvo, E Barroso, L Serrano, T Coll, RM Sánchez, M Merlos, ... Hepatology 49 (1), 106-115, 2009 | 75 | 2009 |
| TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes L Serrano-Marco, MR Chacón, E Maymó-Masip, E Barroso, L Salvadó, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2012 | 69 | 2012 |
